当前位置: 首页 > 详情页

Expression of urotensin II is positively correlated with pyroptosis-related molecules in patients with severe preeclampsia.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [a]Department of Nephrology, Xuanwu Hospital Capital Medical University, Beijing, China [b]Department of Nephrology, Peking University Third Hospital, Beijing, China
出处:
ISSN:

关键词: Preeclampsia UII pyroptosis

摘要:
Purpose: We studied the expression of urotensin II (UII) and its relationships with markers of pyroptosis in preeclampsia. Methods: 48 pregnant subjects were recruited consisting of 28 severe preeclampsia pregnancies (SPE) and 20 healthy pregnancies. We detected expressions of UII and markers of pyroptosis such as NLR-family pyrin domain (PYD)-containing 3 (NLRP-3), caspase-1/4/5, interleukin-1β (IL-1β), and gasdermin D (GSDMD) in placentas of patients with SPE and healthy pregnancies. Results: SPE group have higher expression of UII and NLRP-3, caspase-1, interleukin-1β (IL-1β), and GSDMD than that normal controls by IHC, real-time PCR, and western blot. IHC analysis manifests that the expressions of UII and pyroptosis-related molecules are mainly located in the placental cytotrophoblasts. Expressions of UII mRNA and protein are significantly positively correlated with pyroptosis marker such as NLRP3, caspase-1, GSDMD mRNA and protein by Pearson correlation analysis. Moreover, UII, NLRP-3, caspase-1, interleukin-1β (IL-1β), and GSDMD are positively related with systolic blood pressure, meanwhile caspase-1 and GSDMD are positively correlated with urine protein in SPE patients. We firstly verify that UII has a positive correlation with pyroptosis markers in placentas of preeclampsia patients; besides, pyroptosis-related proteins are positively correlated with systolic blood pressure and urine protein in patients with severe preeclampsia.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 药学
JCR分区:
出版当年[2019]版:
Q4 PERIPHERAL VASCULAR DISEASE Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q3 PERIPHERAL VASCULAR DISEASE Q3 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [a]Department of Nephrology, Xuanwu Hospital Capital Medical University, Beijing, China
共同第一作者:
通讯作者:
通讯机构: [*1]Department of Nephrology, Xuanwu Hospital Capital Medical University, Beijing, PR. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17236 今日访问量:0 总访问量:925 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院